Company
Accustem Sciences Inc. (ACUT)
Standardized SEC financial data for Accustem Sciences Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001850767 · OTC · Pharmaceutical Preparations.
Return on equity
51.6%
Free cash flow
-$861K
Current ratio
0.01×
EPS (diluted)
$-0.12
Income statement
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| R&D expense | $73K | $267K | $140K | $138K | $281K |
| SG&A expense | $597K | $3.5M |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Total current assets | — | $1.4M | $932K | $130K | $50K | $49K |
| Property, plant & equipment |
Cash flow
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating cash flow | -$1.8M | -$1.6M | -$664K | -$850K |
| Capital expenditures | $11K | — | — | — |
Get ACUT data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/ACUT/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/ACUT/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"